Nrg Therapeutics Ltd
11294505
Healthy
No risk factors detected.
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 05/04/2018
DIRECTOR
BRITISH · ENGLAND · Age 56
Also on 1 other board
secretary · Since 02/12/2022
director · Since 06/04/2023
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 52
Also on 2 other boards
director · Since 02/07/2025
MANAGING DIRECTOR
SWISS · SWITZERLAND · Age 53
Also on 1 other board
director · Since 22/08/2025
INVESTMENT ASSOCIATE
DUTCH · NETHERLANDS · Age 31
Persons with Significant Control
Parkinson's Research Ventures Limited
215, Vauxhall Bridge Road, London, SW1V 1EJ
Reg: 11228595 · Companies House · Corporate
Notified 07/07/2022
Former PSCs
Mr Grant Hawthorne
Ceased 30/06/2022
Dr Neil Derek Miller
Ceased 30/06/2022
Dr Anthony Richard Rutter
Ceased 30/06/2022
Parkinson's Research Ventures Limited.
Ceased 01/07/2022
Parkinson's Uk
Ceased 27/06/2019
CompanyRankvs 194+ SIC 72110 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/04/2025
Net Worth
£2.3M
Balance sheet strength
Cash
£3.6M
Cash in the bank
Net Current Assets
£2.3M
Working capital
Current Assets
£4.5M
Current Liabilities
£2.2M
Fixed Assets
£5k
Debtors
£906k
Profit After Tax
-£7.4M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.04 | -£2.6M |
| 2024 | 3.73 | -£7.4M |
| 2023 | 17.09 | +£13.5M |
| 2022 | 8.28 | -£700k |
| 2021 | 4.40 | -£451k |
| 2020 | 0.98 | — |
| 2019 | 1.01 | — |
Derived from filed accounts. Not audited figures.